| Anteris Technologies Global Corp. | 5.18M | US$40.2M | 7.6% |
| Globus Medical, Inc. | 476K | US$35.7M | 6.7% |
| GSK plc | 671K | US$32.3M | 6.1% |
| Senseonics Holdings, Inc. | 2.29M | US$23.3M | 4.4% |
| Merck & Company, Inc. | 145K | US$21.1M | 4.0% |
| IDEAYA Biosciences, Inc. | 500K | US$19.2M | 3.6% |
| Sanofi SA | 356K | US$14.7M | 2.8% |
| Allogene Therapeutics, Inc. | 9.1M | US$14.6M | 2.8% |
| Maximus, Inc. | 268K | US$14.3M | 2.7% |
| Relmada Therapeutics, Inc. | 3.63M | US$13.7M | 2.6% |
| Viatris Inc. | 755K | US$13.4M | 2.5% |
| Aveanna Healthcare Holdings Inc. | 1.01M | US$12.6M | 2.4% |
| Replimune Group, Inc. | 865K | US$11.5M | 2.2% |
| Tango Therapeutics, Inc. | 429K | US$10.7M | 2.0% |
| ANI Pharmaceuticals, Inc. | 146K | US$10.6M | 2.0% |
| BioMarin Pharmaceutical Inc. | 174K | US$10.5M | 2.0% |
| Celcuity Inc. | 126K | US$10M | 1.9% |
| Rapport Therapeutics, Inc. | 291K | US$9.79M | 1.9% |
| Vir Biotechnology, Inc. | 873K | US$9.76M | 1.8% |
| The Cigna Group | 33,935 | US$9.22M | 1.7% |
| The Cooper Companies, Inc. | 158K | US$8.93M | 1.7% |
| Liquidia Corporation | 282K | US$8.53M | 1.6% |
| Cybin, Inc. | 561K | US$6.9M | 1.3% |
| Protara Therapeutics, Inc. | 1.99M | US$6.07M | 1.1% |
| PMV Pharmaceuticals, Inc. | 3.63M | US$6.07M | 1.1% |
| Aquestive Therapeutics, Inc. | 1.28M | US$5.92M | 1.1% |
| PTC Therapeutics, Inc. | 82,900 | US$5.37M | 1.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 766K | US$5.23M | 0.99% |
| Rainier Acquisition Corporation | 500K | US$5.1M | 0.96% |
| Q32 Bio Inc. | 529K | US$4.38M | 0.83% |
| Serina Therapeutics, Inc. | 2M | US$4M | 0.76% |
| Bright Minds Biosciences Inc. | 75,152 | US$3.74M | 0.71% |
| Savara, Inc. | 657K | US$3.39M | 0.64% |
| OnKure Therapeutics, Inc. | 1.08M | US$2.95M | 0.56% |
| AN2 Therapeutics, Inc. | 548K | US$2.92M | 0.55% |
| Immunome, Inc. | 132K | US$2.84M | 0.54% |
| Zenas BioPharma, Inc. | 95,457 | US$2.57M | 0.49% |
| Ovid Therapeutics Inc. | 1.01M | US$2.5M | 0.47% |
| Aligos Therapeutics, Inc. | 327K | US$1.84M | 0.35% |
| Fulcrum Therapeutics, Inc. | 482K | US$1.78M | 0.34% |
| Alignment Healthcare, Inc. | 184K | US$1.5M | 0.28% |
| Xilio Therapeutics, Inc. | 152K | US$1.38M | 0.26% |
| EyePoint, Inc. | 374K | US$1.22M | 0.23% |
| QT Imaging Holdings, Inc. | 440K | US$1.12M | 0.21% |
| iBio, Inc. | 904K | US$1.07M | 0.20% |
| TELA Bio, Inc. | 636K | US$732K | 0.14% |
| Enveric Biosciences, Inc. | 330K | US$490K | 0.09% |
| NeuroOne Medical Technologies Corporation | 82,767 | US$85,250 | 0.02% |
| Modular Medical, Inc. | 26,190 | US$52,380 | <0.01% |
| Bristol-Myers Squibb Company | 0 | US$0 | 0.00% |
| Cencora, Inc. | 0 | US$0 | 0.00% |
| Cross Country Healthcare, Inc. | 0 | US$0 | 0.00% |
| Dianthus Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Ocular Therapeutix, Inc. | 0 | US$0 | 0.00% |
| Oruka Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Regeneron Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Sionna Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| Waystar Holding Corp. | 0 | US$0 | 0.00% |
| Zimmer Biomet Holdings, Inc. | 0 | US$0 | 0.00% |
| Abbott Laboratories | 0 | US$0 | 0.00% |
| Adagio Medical Holdings, Inc | 0 | US$0 | 0.00% |
| Artivion, Inc. | 0 | US$0 | 0.00% |
| BridgeBio Oncology Therapeutics, Inc. | 0 | US$0 | 0.00% |